We obtained primarily diagnosed medulloblastoma (n = 170; 18 WNT, 46 SHH, 41 Group 3, and 65 Group 4) patient-specific mutations and transcriptome data from ICGC (PCAWG, Dec 2020) [12, 36]. This evidence concerns the gene SHH and medulloblastoma.